Cover Image
市場調查報告書

開放性青光眼:全球臨床實驗趨勢

Open-Angle Glaucoma Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 246387
出版日期 內容資訊 英文 379 Pages
訂單完成後即時交付
價格
Back to Top
開放性青光眼:全球臨床實驗趨勢 Open-Angle Glaucoma Global Clinical Trials Review, H2, 2016
出版日期: 2016年11月30日 內容資訊: 英文 379 Pages
簡介

本報告提供開放性青光眼相關之臨床研究最新趨勢分析,疾病·治療方法概要,及G7、E7各國的臨床實驗狀況,各地區、各階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,並彙整有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:開放性青光眼臨床實驗數量佔眼科臨床實驗數量比率

Phase別臨床實驗數量:G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:開放性青光眼臨床實驗數量佔眼科臨床實驗數量比率

Phase別臨床實驗數量:E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

各評估項目臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 開放性青光眼治療藥

有潛力的藥劑

  • 最新臨床實驗新聞:開放性青光眼

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3965CTIDB

GlobalData's clinical trial report, "Open-Angle Glaucoma Global Clinical Trials Review, H2, 2016" provides an overview of Open-Angle Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Five Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Open-Angle Glaucoma Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Latest Clinical Trials News on Open-Angle Glaucoma 30
  • Oct 10, 2016: Allergan to Showcase Abicipar Pegol at the 2016 American Academy of Ophthalmology Annual Meeting in Chicago 30
  • Oct 04, 2016: Ocular Therapeutix Begins Enrollment in First Phase 3 Clinical Trial with OTX-TP (Sustained Release Travoprost) for the Treatment of Glaucoma and Ocular Hypertension 30
  • Clinical Trial Profile Snapshots 32

Appendix 376

  • Abbreviations 376
  • Definitions 376
  • Research Methodology 377
  • Secondary Research 377
  • About GlobalData 378
  • Contact Us 378
  • Disclaimer 378
  • Source 379

List of Tables

List of Tables

  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
  • Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
  • Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
  • Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

List of Figures

  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
  • Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 14
  • Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 17
  • Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 377
Back to Top